 |
|
|
|
|
Utah Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2022 replacing UtahLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Myriad Genetic Laboratories, Inc.
| | | | | Phone: | (801) 584-3600 | | Fax: | (801) 584-3640 | | Year Established: | 1991 | | Employees: | 200 | | Ticker: | MYGN | | Exchange: | NASDAQ | | Main Contact: | Patrick Burke, Executive VP, Emerging Products | | | | Other Contacts: | Bryan M. Dechairo, Executive VP, Clinical Development
Mark C. Capone, President & CEO
Johnathan M. Lancaster, CMO
Jerry Lanchbury, CSO
Richard Marsh, Executive VP & General Counsel
| | | | Company Description | | Myriad Genetics is a leading biopharmaceutical company focused on the development of novel healthcare products. Myriad has a full pipeline of preclinical drug candidates in development including two Phase I human clinical trials for cancer drugs, Azixa™ and MPC-2130. The Company markets molecular diagnostic tests to determine the risk of breast cancer, ovarian cancer, colon cancer, endometrial cancer and melanoma skin cancer in individuals with a family history of cancer. | |
|
|
|
|
|
|
|
